Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek W Ebner

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Medical Economics|April 30, 2024
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screeningJohn B Kisiel, A Mark Fendrick, Derek W Ebner, et al.
Journal of the National Cancer Institute|September 30, 2025
Evaluating benefit-to-burden ratios of the established and emerging colorectal cancer screening strategiesDerek W Ebner, A Mark Fendrick, John B Kisiel, et al.
Gastro Hep Advances|October 25, 2023
Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic SurgeryDerek W Ebner, Kelli N Burger, Brendan Broderick, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 28, 2023
Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without HemorrhoidsDerek W Ebner, David Rushlow, Joshua Mou, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 1, 2024
Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening RatesDerek W Ebner, Lila J Finney Rutten, Lesley-Ann Miller-Wilson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2023
Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of TestingJordan K Voss, Derek W Ebner, Keli N Burger, et al.
Gastro Hep Advances|September 19, 2022
High Positive Predictive Value of Multitarget Stool DNA After Aerodigestive Tract RadiotherapyDerek W Ebner, Jason D Eckmann, Kelli N Burger, et al.
AJPM Focus|November 17, 2025
Comparison of Benefit-to-Burden Ratios for Stool-Based Colorectal Cancer Screening Tests in the U.S.: A Decision Analytical Modeling ApproachJohn B Kisiel, A Mark Fendrick, Derek W Ebner, et al.
Preventive Medicine|December 26, 2024
Adherence to recommended blood-based screening tests for cancer and chronic diseases: A systematic literature reviewQuang A Le, Takako Kiener, Heather A Johnson, et al.
International Journal of Colorectal Disease|February 24, 2025
Re-screening adherence to multi-target stool DNA test for colorectal cancer: real-world study in a large national populationMallik Greene, Timo Pew, Michael Dore, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Medical Economics|April 30, 2024
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screeningJohn B Kisiel, A Mark Fendrick, Derek W Ebner, et al.
Journal of the National Cancer Institute|September 30, 2025
Evaluating benefit-to-burden ratios of the established and emerging colorectal cancer screening strategiesDerek W Ebner, A Mark Fendrick, John B Kisiel, et al.
Gastro Hep Advances|October 25, 2023
Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic SurgeryDerek W Ebner, Kelli N Burger, Brendan Broderick, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 28, 2023
Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without HemorrhoidsDerek W Ebner, David Rushlow, Joshua Mou, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 1, 2024
Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening RatesDerek W Ebner, Lila J Finney Rutten, Lesley-Ann Miller-Wilson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2023
Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of TestingJordan K Voss, Derek W Ebner, Keli N Burger, et al.
Gastro Hep Advances|September 19, 2022
High Positive Predictive Value of Multitarget Stool DNA After Aerodigestive Tract RadiotherapyDerek W Ebner, Jason D Eckmann, Kelli N Burger, et al.
AJPM Focus|November 17, 2025
Comparison of Benefit-to-Burden Ratios for Stool-Based Colorectal Cancer Screening Tests in the U.S.: A Decision Analytical Modeling ApproachJohn B Kisiel, A Mark Fendrick, Derek W Ebner, et al.
Preventive Medicine|December 26, 2024
Adherence to recommended blood-based screening tests for cancer and chronic diseases: A systematic literature reviewQuang A Le, Takako Kiener, Heather A Johnson, et al.
International Journal of Colorectal Disease|February 24, 2025
Re-screening adherence to multi-target stool DNA test for colorectal cancer: real-world study in a large national populationMallik Greene, Timo Pew, Michael Dore, et al.
Pageof 3